Macrogenics (MGNX) Amortizatization of Intangibles (2019 - 2026)

Macrogenics' (MGNX) quarterly Amortizatization of Intangibles came in at $737000.0 in Q1 2026, up 304.95% year-on-year from $182000.0 in Q1 2025, and up 14.44% on a QoQ basis from $644000.0 in Q4 2025.

Macrogenics (MGNX) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends

Macrogenics (MGNX) has 8 years of Amortizatization of Intangibles data on file, last reported at $737000.0 in Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles rose 304.95% year-over-year to $737000.0 in Q1 2026; TTM through Mar 2026 was $2.2 million, a 31.37% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, down 41.35% from the prior year.
  • Amortizatization of Intangibles for Q1 2026 stood at $737000.0, up from $644000.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for MGNX reached as high as $1.9 million in Q3 2023 and fell as low as -$334000.0 in Q1 2022.
  • Historically, Amortizatization of Intangibles has averaged $576235.3 across 5 years, with a median of $372000.0 in 2023.
  • Across the five-year window, Amortizatization of Intangibles surged 1771.43% in 2023 and sank 89.29% in 2024, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $337000.0 in 2022, then surged by 412.76% to $1.7 million in 2023, then plunged by 89.29% to $185000.0 in 2024, then soared by 248.11% to $644000.0 in 2025, then increased by 14.44% to $737000.0 in 2026.
  • Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $737000.0 in Q1 2026, $644000.0 in Q4 2025, and $511000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Macrogenics 255.39 Mn 188.87 Mn - 737,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 737,000.00
Mar 31, 2026 737,000.00
Dec 31, 2025 644,000.00
Dec 31, 2025 644,000.00
Sep 30, 2025 511,000.00
Sep 30, 2025 511,000.00
Jun 30, 2025 311,000.00
Jun 30, 2025 311,000.00
Mar 31, 2025 182,000.00
Mar 31, 2025 182,000.00
Dec 31, 2024 185,000.00
Dec 31, 2024 185,000.00
Sep 30, 2024 371,000.00
Sep 30, 2024 371,000.00
Jun 30, 2024 939,000.00
Jun 30, 2024 939,000.00
Mar 31, 2024 1.32 Mn
Mar 31, 2024 1.32 Mn
Dec 31, 2023 1.73 Mn
Dec 31, 2023 1.73 Mn